Biography

Since September 2020, Dr. Catherine LARUE has been running CoDx, a consulting firm specializing in biotechnology and medical diagnostics. Previously, from 2012 to 2020, she was CEO of IBBL (Integrated BioBank of Luxembourg), where she was involved in developing the biobank's strategy and new initiatives related to personalized medicine. During this time, she also served as interim CEO of the Luxembourg Institute of Health (LIH), the Luxembourg Biomedical Research Institute, for nearly two years. Before joining IBBL, Dr. Catherine LARUE led the “Biomarkers” program at GENFIT until 2012. Dr. Catherine LARUE began her career as a Team Leader at Sanofi in R&D in the Cardiovascular Research Department. She then joined Sanofi Diagnostics Pasteur, where she worked as R&D Director in France and the US, before spending 11 years with the Bio-Rad group, where she held various management positions. She has been involved in the discovery of several innovative biomarkers and the marketing of dozens of diagnostic products. Dr. Catherine Larue holds a PhD in experimental biology and a Habilitation à Diriger la Recherche (HDR) from the University of Rouen, a university degree in clinical oncology (University of Paris VI), and an Executive MBA (ISM-St. John's University, New York). She was recently certified in the CSRD directive.